当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 利润表

南京医药

(600713)

  

流通市值:63.85亿  总市值:64.75亿
流通股本:12.90亿   总股本:13.08亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入41,686,951,461.2727,822,576,569.9513,843,779,763.654,963,277,449.95
  营业收入41,686,951,461.2727,822,576,569.9513,843,779,763.654,963,277,449.95
二、营业总成本40,821,636,986.227,234,806,874.9813,504,978,803.1753,921,722,737.41
  营业成本39,132,594,388.1126,145,385,652.2212,974,407,093.4651,580,940,619.15
  税金及附加76,548,609.0749,267,514.3224,611,029.72118,997,032.71
  销售费用876,180,604.84571,359,933.76286,479,151.721,199,699,696.55
  管理费用374,260,660.61231,526,826.98105,351,276.04513,476,954.57
  研发费用30,525,360.1616,553,690.487,611,588.146,789,558.57
  财务费用331,527,363.41220,713,257.22106,518,664.13461,818,875.86
  其中:利息费用217,617,158.75139,864,841.6664,813,863.01309,014,785.81
  其中:利息收入9,901,605.885,903,983.133,467,849.9220,635,964.17
三、其他经营收益
  加:公允价值变动收益373,698.63410,597.27199,024.66282,526.03
  加:投资收益4,866,934.363,530,736.72-1,433,268.664,793,861.74
  资产处置收益2,861,382.172,970,207.791,185,480.36293,733,418.4
  资产减值损失(新)-6,198,866.59-4,212,882.79-2,385,726.25-25,113,091.63
  信用减值损失(新)-117,409,462.44-79,002,585.25-60,713,770.45-185,371,662.12
  其他收益21,350,067.0915,045,552.839,028,992.9530,226,515.95
四、营业利润771,158,228.29526,511,321.54284,681,693.041,160,106,280.91
  加:营业外收入12,241,655.7210,566,870.312,234,660.1239,758,236.98
  减:营业外支出23,181,386.813,736,433.614,998,795.2642,236,584.17
五、利润总额760,218,497.21523,341,758.24281,917,557.91,157,627,933.72
  减:所得税费用215,377,144.83144,840,734.0570,220,113.31324,959,057.2
六、净利润544,841,352.38378,501,024.19211,697,444.59832,668,876.52
(一)按经营持续性分类
  持续经营净利润544,841,352.38378,501,024.19211,697,444.59832,668,876.52
(二)按所有权归属分类
  归属于母公司股东的净利润415,220,100.09294,471,241.89174,569,585.5624,834,794.91
  少数股东损益129,621,252.2984,029,782.337,127,859.09207,834,081.61
  扣除非经常损益后的净利润404,485,737.91282,916,751.36168,888,007.4421,334,367.89
七、每股收益
  (一)基本每股收益0.320.230.140.48
  (二)稀释每股收益0.280.20.120.43
八、其他综合收益-24,521,011.89-19,006,250.54-13,095,362.19-10,643,046.56
  归属于母公司股东的其他综合收益-25,215,800.05-19,897,340.35-13,236,476.9-10,478,551.81
九、综合收益总额520,320,340.49359,494,773.65198,602,082.4822,025,829.96
  归属于母公司股东的综合收益总额390,004,300.04274,573,901.54161,333,108.6614,356,243.1
  归属于少数股东的综合收益总额130,316,040.4584,920,872.1137,268,973.8207,669,586.86
公告日期2026-10-312026-08-292026-04-302026-04-11
审计意见(境内)标准无保留意见
TOP↑